651 related articles for article (PubMed ID: 26368019)
21. Synergistic antitumor effect of 5-fluorouracil in combination with parthenolide in human colorectal cancer.
Kim SL; Kim SH; Trang KT; Kim IH; Lee SO; Lee ST; Kim DG; Kang SB; Kim SW
Cancer Lett; 2013 Jul; 335(2):479-86. PubMed ID: 23507557
[TBL] [Abstract][Full Text] [Related]
22. 53BP1 loss induces chemoresistance of colorectal cancer cells to 5-fluorouracil by inhibiting the ATM-CHK2-P53 pathway.
Yao J; Huang A; Zheng X; Liu T; Lin Z; Zhang S; Yang Q; Zhang T; Ma H
J Cancer Res Clin Oncol; 2017 Mar; 143(3):419-431. PubMed ID: 27838786
[TBL] [Abstract][Full Text] [Related]
23. An apple oligogalactan enhances the growth inhibitory effect of 5-fluorouracil on colorectal cancer.
Li Y; Fan L; Niu Y; Mian W; Zhang F; Xie M; Sun Y; Mei Q
Eur J Pharmacol; 2017 Jun; 804():13-20. PubMed ID: 28389232
[TBL] [Abstract][Full Text] [Related]
24. MEK5/ERK5 signaling inhibition increases colon cancer cell sensitivity to 5-fluorouracil through a p53-dependent mechanism.
Pereira DM; Simões AE; Gomes SE; Castro RE; Carvalho T; Rodrigues CM; Borralho PM
Oncotarget; 2016 Jun; 7(23):34322-40. PubMed ID: 27144434
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of EZH2 enhances the therapeutic effect of 5-FU via PUMA upregulation in colorectal cancer.
Tan X; Zhang Z; Liu P; Yao H; Shen L; Tong JS
Cell Death Dis; 2020 Dec; 11(12):1061. PubMed ID: 33311453
[TBL] [Abstract][Full Text] [Related]
26. The synthetic flavonoid WYC02-9 inhibits colorectal cancer cell growth through ROS-mediated activation of MAPK14 pathway.
Chen YJ; Chen HP; Cheng YJ; Lin YH; Liu KW; Chen YJ; Hou MF; Wu YC; Lee YC; Yuan SS
Life Sci; 2013 Jun; 92(22):1081-92. PubMed ID: 23624232
[TBL] [Abstract][Full Text] [Related]
27. Panaxadiol, a purified ginseng component, enhances the anti-cancer effects of 5-fluorouracil in human colorectal cancer cells.
Li XL; Wang CZ; Mehendale SR; Sun S; Wang Q; Yuan CS
Cancer Chemother Pharmacol; 2009 Nov; 64(6):1097-104. PubMed ID: 19277659
[TBL] [Abstract][Full Text] [Related]
28. Esculetin enhances the inhibitory effect of 5-Fluorouracil on the proliferation, migration and epithelial-mesenchymal transition of colorectal cancer.
Yan L; Yu HH; Liu YS; Wang YS; Zhao WH
Cancer Biomark; 2019; 24(2):231-240. PubMed ID: 30689555
[TBL] [Abstract][Full Text] [Related]
29. Manuka honey synergistically enhances the chemopreventive effect of 5-fluorouracil on human colon cancer cells by inducing oxidative stress and apoptosis, altering metabolic phenotypes and suppressing metastasis ability.
Afrin S; Giampieri F; Forbes-Hernández TY; Gasparrini M; Amici A; Cianciosi D; Quiles JL; Battino M
Free Radic Biol Med; 2018 Oct; 126():41-54. PubMed ID: 30056083
[TBL] [Abstract][Full Text] [Related]
30. Curcumin Reverses NNMT-Induced 5-Fluorouracil Resistance via Increasing ROS and Cell Cycle Arrest in Colorectal Cancer Cells.
Li G; Fang S; Shao X; Li Y; Tong Q; Kong B; Chen L; Wang Y; Yang J; Yu H; Xie X; Zhang J
Biomolecules; 2021 Aug; 11(9):. PubMed ID: 34572508
[TBL] [Abstract][Full Text] [Related]
31. Weichang'an and 5-fluorouracil suppresses colorectal cancer in a mouse model.
Tao L; Yang JK; Gu Y; Zhou X; Zhao AG; Zheng J; Zhu YJ
World J Gastroenterol; 2015 Jan; 21(4):1125-39. PubMed ID: 25632185
[TBL] [Abstract][Full Text] [Related]
32. 3'-hydroxy-4'-methoxy-β-methyl-β-nitrostyrene inhibits tumorigenesis in colorectal cancer cells through ROS-mediated DNA damage and mitochondrial dysfunction.
Tsai CH; Hung AC; Chen YY; Chiu YW; Hsieh PW; Lee YC; Su YH; Chang PC; Hu SC; Yuan SF
Oncotarget; 2017 Mar; 8(11):18106-18117. PubMed ID: 28178649
[TBL] [Abstract][Full Text] [Related]
33. Icariin-mediated inhibition of NF-κB activity enhances the in vitro and in vivo antitumour effect of 5-fluorouracil in colorectal cancer.
Shi DB; Li XX; Zheng HT; Li DW; Cai GX; Peng JJ; Gu WL; Guan ZQ; Xu Y; Cai SJ
Cell Biochem Biophys; 2014 Jul; 69(3):523-30. PubMed ID: 24435883
[TBL] [Abstract][Full Text] [Related]
34. Ganoderma Lucidum induces oxidative DNA damage and enhances the effect of 5-Fluorouracil in colorectal cancer in vitro and in vivo.
Opattova A; Horak J; Vodenkova S; Kostovcikova K; Cumova A; Macinga P; Galanova N; Rejhova A; Vodickova L; Kozics K; Turnovcova K; Hucl T; Sliva D; Vodicka P
Mutat Res Genet Toxicol Environ Mutagen; 2019 Sep; 845():403065. PubMed ID: 31561886
[TBL] [Abstract][Full Text] [Related]
35. Reactivating p53 and Inducing Tumor Apoptosis (RITA) Enhances the Response of RITA-Sensitive Colorectal Cancer Cells to Chemotherapeutic Agents 5-Fluorouracil and Oxaliplatin.
Wiegering A; Matthes N; Mühling B; Koospal M; Quenzer A; Peter S; Germer CT; Linnebacher M; Otto C
Neoplasia; 2017 Apr; 19(4):301-309. PubMed ID: 28284059
[TBL] [Abstract][Full Text] [Related]
36. Notoginseng enhances anti-cancer effect of 5-fluorouracil on human colorectal cancer cells.
Wang CZ; Luo X; Zhang B; Song WX; Ni M; Mehendale S; Xie JT; Aung HH; He TC; Yuan CS
Cancer Chemother Pharmacol; 2007 Jun; 60(1):69-79. PubMed ID: 17009031
[TBL] [Abstract][Full Text] [Related]
37. Combined 5-FU and ChoKα inhibitors as a new alternative therapy of colorectal cancer: evidence in human tumor-derived cell lines and mouse xenografts.
de la Cueva A; Ramírez de Molina A; Alvarez-Ayerza N; Ramos MA; Cebrián A; Del Pulgar TG; Lacal JC
PLoS One; 2013; 8(6):e64961. PubMed ID: 23762272
[TBL] [Abstract][Full Text] [Related]
38. microRNA-577 suppresses tumor growth and enhances chemosensitivity in colorectal cancer.
Jiang H; Ju H; Zhang L; Lu H; Jie K
J Biochem Mol Toxicol; 2017 Jun; 31(6):. PubMed ID: 28150434
[TBL] [Abstract][Full Text] [Related]
39. CTCF promotes colorectal cancer cell proliferation and chemotherapy resistance to 5-FU via the P53-Hedgehog axis.
Lai Q; Li Q; He C; Fang Y; Lin S; Cai J; Ding J; Zhong Q; Zhang Y; Wu C; Wang X; He J; Liu Y; Yan Q; Li A; Liu S
Aging (Albany NY); 2020 Jul; 12(16):16270-16293. PubMed ID: 32688344
[TBL] [Abstract][Full Text] [Related]
40. Nobiletin induces apoptosis and potentiates the effects of the anticancer drug 5-fluorouracil in p53-mutated SNU-16 human gastric cancer cells.
Moon JY; Cho M; Ahn KS; Cho SK
Nutr Cancer; 2013; 65(2):286-95. PubMed ID: 23441616
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]